Showing results (51-60 of 237) with videos related to
Sort By:
Pageof 24
Current Vascular Pharmacology|February 15, 2011
What restricts the clinical use of nicotinic acid?Anastazia Kei, Evangelos N Liberopoulos, Moses S ElisafDiseases (Basel, Switzerland)|September 30, 2017
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?Theodosios D Filippatos, Anastazia Kei, Moses S ElisafWorld Journal of Hepatology|September 28, 2013
Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver diseaseMichael S Kostapanos, Anastazia Kei, Moses S ElisafEuropean Journal of Pharmacology|March 5, 2016
Electrolyte disorders associated with the use of anticancer drugsGeorge Liamis, Theodosios D Filippatos, Moses S ElisafExpert Opinion on Drug Metabolism & Toxicology|November 8, 2016
Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversiesVasilios Tsimihodimos, Theodosios D Filippatos, Moses S ElisafExpert Review of Clinical Pharmacology|April 29, 2014
Treatment of hyponatremia: the role of lixivaptanGeorge Liamis, Theodosios D Filippatos, Moses S ElisafPostgraduate Medicine|March 28, 2015
Correction of hypovolemia with crystalloid fluids: Individualizing infusion therapyGeorge Liamis, Theodosios D Filippatos, Moses S ElisafPostgraduate Medicine|May 7, 2016
Ten pitfalls in the proper management of patients with hyponatremiaTheodosios D Filippatos, George Liamis, Moses S ElisafArchives of Toxicology|May 12, 2016
The current role of thiazolidinediones in diabetes managementChristos V Rizos, Anastazia Kei, Moses S ElisafJournal of Geriatric Cardiology : JGC|May 12, 2016
Thiazide-associated hyponatremia in the elderly: what the clinician needs to knowGeorge Liamis, Theodosios D Filippatos, Moses S ElisafPageof 24